CAS: 123663-49-0 - Iguratimod
Formula:C17H14N2O6S
InChI:InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)
InChI key:InChIKey=ANMATWQYLIFGOK-UHFFFAOYSA-N
SMILES:O=CNC1=COC=2C=C(NS(=O)(=O)C)C(OC=3C=CC=CC3)=CC2C1=O
- Synonyms:
- 3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one
- Ailamode
- Careram
- Kolbet
- Methanesulfonamide, N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]-
- N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide
- N-[3-(formylamino)-4-oxo-6-phenoxy-4H-chromen-7-yl]methanesulfonamide
- N-[7-methanesulfonamido-4-oxo-6-(phenoxy)chromen-3-yl]formamide
- T 614
- T 614 (antiinflammatory)
- See more synonyms
- iguratimod( R&D)
- Iguratimod
Methanesulfonamide, N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]-
CAS:123663-49-0
Formula:
C17H14N2O6S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
374.3679
Ref: IN-DA000KXN
1g | 78.00 € | ||
5g | 199.00 € | ||
10g | 498.00 € | ||
25g | To inquire | ||
25mg | 24.00 € | ||
50mg | 27.00 € | ||
100mg | 41.00 € | ||
250mg | 48.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Iguratimod
CAS:123663-49-0
Formula:
C17H14N2O6S
Color and Shape:
White To Off-White Solid
Molecular weight:
374.37
Ref: 4Z-I-092001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-I-092033
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Iguratimod
CAS:123663-49-0
Formula:
C17H14N2O6S
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
374.37
Ref: 3B-I0945
25mg | 29.00 € | ||
250mg | 132.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Iguratimod
CAS:123663-49-0
Iguratimod (T614) is a COX-2 inhibitor (IC50: 20 μM), does not affect COX-1, and inhibits …
Formula:
C17H14N2O6S
Purity:
99.96%
Color and Shape:
White Powder
Molecular weight:
374.37
Ref: TM-T5032
5mg | 56.00 € | ||
10mg | 71.00 € | ||
25mg | 115.00 € | ||
50mg | 198.00 € | ||
100mg | 255.00 € | ||
1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide
CAS:123663-49-0
Purity:
95.0%
Molecular weight:
374.3699951171875
- Sulphur (S) Compounds
- Ethers
- Amides
- 6-membered Heterocycles
- See more categories
- Ether and Impurities
Ref: 10-F213725
1g | To inquire | ||
5g | To inquire | ||
10g | To inquire | ||
25g | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Iguratimod
CAS:123663-49-0
Positive regulator of NF-κB and RANKL; anti-rheumatic; anti-inflammatory
Formula:
C17H14N2O6S
Purity:
Min. 95%
Color and Shape:
White Clear Liquid
Molecular weight:
374.37 g/mol
Ref: 3D-FI39374
1g | 896.00 € | ||
50mg | 144.00 € | ||
100mg | 217.00 € | ||
250mg | 356.00 € | ||
500mg | 542.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Iguratimod - Bio-X ™
CAS:123663-49-0
Iguratimod is a drug that is used to treat autoimmune and inflammatory conditions such as …
Formula:
C17H14N2O6S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
374.37 g/mol
Ref: 3D-BI164569
10mg | 136.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Iguratimod
Controlled ProductCAS:123663-49-0
Applications Iguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis. …
Formula:
C17H14N2O6S
Color and Shape:
Neat
Molecular weight:
374.37
Ref: TR-I265100
25mg | 90.00 € | ||
50mg | 158.00 € | ||
100mg | 283.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Iguratimod-d5
Controlled ProductCAS:123663-49-0
Formula:
C17D5H9N2O6S
Color and Shape:
Neat
Molecular weight:
379.399
Ref: TR-I265102
100mg | 27,286.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025